|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||0.09 - 0.09|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The lawyers, who did not wish to be named as the decision was not public, did not disclose the terms of the arbitration ruling. Mahyco Monsanto Biotech (India) (MMB), a joint venture between Missouri-based Monsanto and India's Maharashtra Hybrid Seeds Co (Mahyco), "has received a favorable award from the arbitration panel in the proceedings against NSL and Prabhat", a Bayer spokesman said in an e-mailed statement when asked about the ruling.
Paul Francois, who says he fell ill after inhaling vapor from weedkiller Lasso in 2004, won rulings in 2012 and 2015 that found Monsanto liable for the intoxication, before France's top court overturned those decisions and ordered a new hearing. An appeal court in the southeastern French city of Lyon will hear arguments on Wednesday before giving its verdict at a later date. Francois, who says he has suffered memory loss, headaches and stammering, blames Monsanto for not giving sufficient warnings on the product label.
NEW DELHI/MUMBAI (Reuters) - India's Supreme Court ruled on Tuesday that Monsanto can claim patents on its genetically modified (GM) cotton seeds, a victory for the U.S. company that is expected to encourage biotechnology firms to step up investment in the country. The decision on appeal overturns an earlier ruling by the Delhi High Court that Monsanto - the world's biggest seed maker, which has been bought by Germany's Bayer AG - could not claim patents on GM cotton seeds.
SolomonEdwards, a national professional services firm, has added Kimberly Rodichok to its consulting team as a Director in their Technical Accounting and Regulatory Advisory Services Practice. As Director, Kimberly joins Brian McAuliffe, both of whom will support Greater Washington D.C. metro businesses in the areas of business transformation and project management. Kimberly, a seasoned management consultant with an accomplished history of providing counsel to federal clients, has a proven track record of effectively overseeing teams and elaborate projects.
Agribusiness giant Monsanto on Tuesday appealed a $78 million verdict in favour of a dying California man who said the company's widely used Roundup weed killer was a major factor in his cancer. The company filed a notice of appeal in San Francisco Superior Court challenging a jury verdict in favour of DeWayne Johnson. Monsanto had sought a new trial or judgment in its favour .
A San Francisco judge on Monday upheld a jury verdict that found Monsanto liable for not warning a groundskeeper that its weed killer Roundup might cause cancer, but slashed the damages award.
Dewayne ‘Lee’ Johnson reacts after hearing the verdict in his case against Monsanto. A California judge has rejected Monsanto’s appeal to overturn a landmark jury verdict which found that its popular herbicide causes cancer. The judge’s ruling on Monday largely sided with Dewayne “Lee” Johnson, a father of three and former school groundskeeper, who won a $289m award over the summer after alleging that his exposure to Roundup weedkiller gave him cancer.
SAO PAULO (Reuters) - A Brazilian appeals court denied a request this month by Monsanto's local unit to suspend licensing of its popular Intacta soy seed technology to privately owned seed maker Sementes Talismã, according to a ruling seen by Reuters.
The company said in motions filed in San Francisco's Superior Court of California that the jury's decision was insufficiently supported by the evidence presented at trial by school groundskeeper Dewayne Johnson. Johnson's case, filed in 2016, was fast-tracked for trial due to the severity of his non-Hodgkin's lymphoma, a cancer of the lymph system, that he alleged was caused by years of exposure to Roundup and Ranger Pro, another Monsanto herbicide that contains glyphosate. Monsanto asked Superior Court Judge Suzanne Bolanos, who oversaw the trial, to set aside the verdict or, in the alternative, reduce the award or grant a new trial.
The weaker earnings forecast adds to a number of challenges facing the German drugmaker as it braces for years of legal wrangling over the alleged cancer risks of glyphosate-based weedkillers. Bayer said the number of plaintiffs seeking damages over Monsanto's Roundup and Ranger Pro herbicides had risen to 8,700 from 8,000 from last month, and said that it expected more to sue. The company lowered its forecast for adjusted core earnings per share for the year to 5.70 - 5.90 euros, down from 6.64 in 2017, short of analyst expectations, dragging the stock down as much as 3.7 percent in morning trade.
The groups, which filed a lawsuit in February, want the court to force the EPA to vacate its approval of XtendiMax, arguing it not only harms nearby crops and plants but wildlife as well. It is not clear whether the court has the authority to revoke an EPA approval. The United States has faced a weed-killer crisis caused by the new formulations of dicamba-based herbicides, which farmers and weed experts say have harmed crops because they evaporate and drift away from where they are applied.
Last summer, after farmers planted Monsanto's dicamba-resistant soy seeds en masse, the herbicide drifted onto nearby farms and damaged an estimated 3.6 million acres of non-resistant soybeans, or 4 percent of all U.S. plantings. The U.S. Environmental Protection Agency (EPA) is now weighing such complaints as part of a high-stakes decision on the herbicide's future. Bayer bought Monsanto and its portfolio of dicamba-resistant Xtend brand soy seeds for $63 billion this year in a deal that created the world's largest seed and pesticides maker.
Bayer can begin folding Monsanto into its organisation as the antitrust-related sale of assets has been completed, fulfilling final requirements by the U.S. Department of Justice, the German drugmaker said on Thursday. "The integration of Monsanto into the Bayer Group can begin following the completion on Thursday of the divestment by Bayer to BASF of certain Crop Science businesses with a total sales volume of around 2.2 billion euros (£1.97 billion)," it said in a statement. Bayer already closed the deal, becoming the sole owner of Monsanto, on June 7 but had to hold off on the integration.
Last week's verdict ended the first trial over whether glyphosate, the main ingredient in Roundup, causes cancer. Monsanto, which says decades of scientific studies have shown Roundup and glyphosate are safe, is facing about 5,000 similar lawsuits nationwide. Monsanto said on Monday it planned to challenge the verdict on the grounds that the judge should have barred scientific evidence presented by California school groundskeeper Dewayne Johnson's lawyers as insufficient.